Iris Acquisition Corp II (IRAB)

Iris Acquisition Corp II is a blank-check company or special purpose acquisition company that does not have significant operations and was formed to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses. It pursues a generalist investment approach targeting high-quality mid-market companies globally. The company was incorporated as a Cayman Islands exempted company.

Market
NYSE
Trend
Uptrend
Last close
10.01 (0% on the day)
MA50
10.01
52-week range
9.82–10.15
Market cap
229.3M USD
Dividend yield
0%
Data as of
2026-06-30
Quarterly revenue and earnings, millions of USD
QuarterRevenueYoY %EarningsYoY %
Q3 20250—-0.1—
Q4 20250—-0—
Q1 20260—0.8—
Q2 20260—1.3—

All markets — KeepWinning global stock screener

Other companies on NYSE: Evommune, Inc. (EVMN), MBIA Inc. (MBI), SEACOR Marine Holdings Inc. (SMHI), ADC Therapeutics SA (ADCT), Disciplined Growth Acquisition Corporation (DGAC), B&G Foods, Inc. (BGS)